Genotyping Panel for Cancer Chemotherapy Response
Author Information
Author(s): Dai Zunyan, Papp Audrey C, Wang Danxin, Hampel Heather, Sadee Wolfgang
Primary Institution: The Ohio State University
Hypothesis
The study aims to establish a high-throughput genotyping platform for genes involved in cancer chemotherapy response.
Conclusion
The genotyping panel is effective for identifying genetic variations that influence individual responses to cancer treatment.
Supporting Evidence
- 408 out of 432 SNPs were successfully genotyped, indicating high precision.
- The genotyping method can process up to 10,000 SNPs per hour.
- Genotyping panels can be expanded as new genetic variants are discovered.
- Successful genotyping was achieved in both leukemia and colorectal cancer patient samples.
Takeaway
Scientists created a test to see how people's genes affect their reactions to cancer drugs, helping doctors give better treatments.
Methodology
The study used SNPlex to genotype 432 SNPs in 160 candidate genes across 129 patients with chronic lymphocytic leukemia and colorectal cancer.
Limitations
The genotyping panels may not cover all functional SNPs and are limited to known polymorphisms.
Participant Demographics
39 patients with chronic lymphocytic leukemia and 90 patients with colorectal cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website